Code | 37219 | ||||||||||
MA number | EU/1/03/256/009 | ||||||||||
Product Form: | sol inj 4x0,8 ml/40 mg (napl.skl.pero) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | AbbVie Deutschland GmbH & Co. KG, Germany | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 08.09.2003 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 25.01.2022 |